IP Library › Granted Patent US 8,101,575
Granted Patent B2
US 8,101,575 · App. 12/715,554 · Granted Jan 24, 2012

Glycopeptide phosphonate derivatives

Assignee: Theravance, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,101,575
App. No.
12/715,554
Granted
Jan 24, 2012
Kind
B2
Abstract

Disclosed are glycopeptides that are substituted with one or more substituents each comprising one or more phosphono groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.

Claims (3)

1. A composition comprising water and a compound of the formula:

2. A composition comprising water and a salt of a compound of the formula:

3. A composition comprising water and a hydrochloride salt of a compound of the formula:

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033181/0646 →
Continuity (8)
Continuation 11977429 · Oct 24, 2007
Continuation 11584908 · Oct 23, 2006
Continuation 11265570 · Nov 2, 2005
Continuation 11037934 · Jan 18, 2005
Continuation 10669778 · Sep 24, 2003
Continuation 09847042 · May 1, 2001
Provisional Application 60213410 · Jun 22, 2000
Related Publication 20100160211A1 · Jun 24, 2010